Title : Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells - Han_2020_FEBS.Open.Bio_10_2375 |
Author(s) : Han B , Lee-Okada HC , Ishimine M , Orita H , Nishikawa K , Takagaki T , Kajino K , Yokomizo T , Hino O , Kobayashi T |
Ref : FEBS Open Bio , 10 :2375 , 2020 |
Abstract : Han_2020_FEBS.Open.Bio_10_2375 |
ESTHER : Han_2020_FEBS.Open.Bio_10_2375 |
PubMedSearch : Han_2020_FEBS.Open.Bio_10_2375 |
PubMedID: 32961616 |
Han B, Lee-Okada HC, Ishimine M, Orita H, Nishikawa K, Takagaki T, Kajino K, Yokomizo T, Hino O, Kobayashi T (2020)
Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells
FEBS Open Bio
10 :2375
Han B, Lee-Okada HC, Ishimine M, Orita H, Nishikawa K, Takagaki T, Kajino K, Yokomizo T, Hino O, Kobayashi T (2020)
FEBS Open Bio
10 :2375